Solactive G2 Innovative Drugs Index NTR
Tracks securities tied to innovative drug development across areas like oncology, immunology, metabolic, cardiovascular, infectious diseases, and vaccines. Aims for long-term growth by investing in leading biopharma companies.
Master Data
| ISIN: | DE000SL0TPK1 |
| Bloomberg Ticker: | |
| WKN: | SL0TPK |
Current Quotes
| Last quote (08 Apr 2026): | 3364.34 |
| Day range: | 3354.65 / 3434.00 |
| Change abs./rel.: | -46.67 / -1.37% |
| Year range: | 2040.71 / 3553.38 |
| Name | Number of shares |
|---|---|
| BIOGEN INC | 0.011414 |
| SIMCERE PHARMACEUTICAL GROUP | 1.114726 |
| NOVO-NORDISK A/S-SPONS ADR | 0.331217 |
| ALNYLAM PHARMACEUTICALS INC | 0.010352 |
| 3SBIO INC | 6.896127 |
| GSK PLC-SPON ADR | 0.06327 |
| REMEGEN CO LTD-H | 0.590894 |
| CSPC PHARMACEUTICAL GROUP LTD | 10.280416 |
| PFIZER INC | 0.17171 |
| HANSOH PHARMACEUTICAL GROUP CO | 3.150703 |
| ELI LILLY & CO | 0.052095 |
| NOVARTIS AG-SPONSORED ADR | 0.064321 |
| BRISTOL-MYERS SQUIBB CO | 0.115098 |
| ASTRAZENECA PLC | 0.079589 |
| SINO BIOPHARMACEUTICAL LTD ORD | 13.680449 |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.083223 |
| ZAI LAB LTD | 2.890768 |
| LIVZON PHARMACEUTICAL GROUP INC | 0.116609 |
| SKB BIO-B ORD H | 0.17727 |
| EVEREST MEDICINES LTD | 1.096346 |
| INNOCARE PHARMA LTD | 3.501877 |
| ABBVIE INC | 0.085277 |
| REGENERON PHARMACEUTICALS | 0.00526 |
| HENGRUI PHARMA ORD H | 0.479288 |
| KEYMED BIOSCIENCES INC | 0.799684 |
| AMGEN INC | 0.015944 |
| INCYTE CORP | 0.016529 |
| GENMAB A/S | 0.065677 |
| UNITED THERAPEUTICS CORP | 0.003357 |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 0.552642 |
| AKESO INC | 2.453807 |
| LUYE PHARMA GROUP LTD | 3.282859 |
| MODERNA INC | 0.034524 |
| GILEAD SCIENCES INC | 0.109179 |
| INNOVENT BIOLOGICS INC | 4.564843 |
| TAKEDA PHARM-ADR | 0.101662 |
| LEPU BIOPHARMA CO LTD-H | 3.074126 |
| BEONE MEDICINES LTD | 2.189234 |
| ROYALTY PHARMA PLC- CL A | 0.016202 |
| SANOFI-ADR | 0.079286 |